Medisafe

Other Healthcare Technology Systems · Boston, MA · Founded 2012 · Privately Held (backing)

Developer of a medication management platform designed to address significant causes of non-adherence to medication schedules. Medisafe is based in Boston, MA and was founded in 2012. It has raised $51.5 million across 1 recorded round; the latest was a $30 million Series C in Feb 2021.

Last price · $/share
—
Implied valuation
—
Total raised
$51.5M
Last round
Later Stage VC (Series C)
Feb 2021
Valuation — not yet established

No valuation for Medisafe is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($51.5M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Medisafe with a free account
  • ·The complete investor list: 24 names
  • ·Watch Medisafe: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Medisafe funding history

1 rounds
DateRoundRaisedPost-money
Feb 2021Later Stage VC (Series C)$30.0M▮
Unlock post-money valuations

Membership and data by Private Market View

How much has Medisafe raised?

Medisafe has raised $51.5 million in total; 1 of its rounds is on record. The largest on record was a $30 million Series C in Feb 2021.

How Medisafe's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Medisafe, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked about Medisafe

How much has Medisafe raised?
Medisafe has raised $51.5M in total funding across 1 recorded rounds.
When did Medisafe last raise?
Medisafe last raised in Feb 2021 (Later Stage VC (Series C)), raising $30.0M.